Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

NCT01652157 · clinicaltrials.gov ↗

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Fibrosing Colonopathy

Interventions

BIOLOGICAL: ULTRESA
BIOLOGICAL: PANCREAZE
BIOLOGICAL: CREON
BIOLOGICAL: ZENPEP
BIOLOGICAL: other non-sponsor pancreatic enzyme replacement therapy
BIOLOGICAL: PERTZYE
OTHER: No pancreatic enzyme replacement therapy

Sponsor

AbbVie

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]